Does TREMELIMUMAB\TREMELIMUMAB-ACTL Cause Immune-mediated hepatic disorder? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Immune-mediated hepatic disorder have been filed in association with TREMELIMUMAB\TREMELIMUMAB-ACTL. This represents 3.8% of all adverse event reports for TREMELIMUMAB\TREMELIMUMAB-ACTL.
45
Reports of Immune-mediated hepatic disorder with TREMELIMUMAB\TREMELIMUMAB-ACTL
3.8%
of all TREMELIMUMAB\TREMELIMUMAB-ACTL reports
6
Deaths
19
Hospitalizations
How Dangerous Is Immune-mediated hepatic disorder From TREMELIMUMAB\TREMELIMUMAB-ACTL?
Of the 45 reports, 6 (13.3%) resulted in death, 19 (42.2%) required hospitalization, and 7 (15.6%) were considered life-threatening.
Is Immune-mediated hepatic disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREMELIMUMAB\TREMELIMUMAB-ACTL. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does TREMELIMUMAB\TREMELIMUMAB-ACTL Cause?
Diarrhoea (109)
Death (106)
Malignant neoplasm progression (101)
Cytokine release syndrome (86)
Immune-mediated enterocolitis (63)
Liver disorder (62)
Pyrexia (61)
Rash (60)
Colitis (47)
Interstitial lung disease (41)
What Other Drugs Cause Immune-mediated hepatic disorder?
PEMBROLIZUMAB (923)
NIVOLUMAB (486)
IPILIMUMAB (318)
CARBOPLATIN (188)
PACLITAXEL (144)
DURVALUMAB (102)
LENVATINIB (100)
PEMETREXED (67)
AXITINIB (53)
CABOZANTINIB S-MALATE (45)
Which TREMELIMUMAB\TREMELIMUMAB-ACTL Alternatives Have Lower Immune-mediated hepatic disorder Risk?
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TRENBOLONE
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREOSULFAN
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREPROSTINIL
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREPROSTINIL DIOLAMINE
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TRETINOIN